The Times of India brings the Latest & Top Breaking News on Politics and Current Affairs in India & around the World, Cricket, Sports, Business, Bollywood News and Entertainment, Science, Technology, ...

Instead of capturing a memory with an iPhone camera, Carnegie Mellon University's Nivedita Shyamsundar used hers to make a scientific discovery.

A MATLAB-based GUI for estimating grafting density of polymer-grafted gold nanoparticles from UV–vis LSPR peak shifts. GraftCal combines experimental peak-position data with optical modeling to pro...

Nanoparticles could someday provide a new way to help soldiers fight back against deadly nerve agents on the front lines.

Nanoparticles could someday provide a new way to help soldiers fight back against deadly nerve agents on the front lines.

MIT engineers have found a way to stabilize the lipid nanoparticles used to deliver RNA vaccines, which could allow the vaccines to be more widely distributed. RNA vaccines, which have been proven effective against Covid-19, are now being developed for many other diseases, including cancer. One of the drawbacks to these vaccines is that they require ultracold storage, but researchers from MIT have found a promising way to overcome that limitation. With help from an AI algorithm, the researchers tweaked the formulation surrounding the lipid nanoparticles that are typically used to deliver mRNA vaccines, making the vaccines more heat-resistant. Using this approach, they formulated vaccines that could remain stable even when stored at room temperature for up to a year, or at nearly 100 degrees Fahrenheit for two months. When Covid-19 vaccines carried by these particles were administered to mice, they generated just as strong an immune response as an RNA Covid-19 vaccine similar to one developed by Moderna. By using the AI algorithm to predict the optimal formulations for the particles, the researchers were able to cut down the number of experiments they needed to do, which rapidly sped up the development process. “The real beauty of this algorithm...

Researchers found that scented cleaners can react with ozone indoors to create billions or trillions of invisible nanoparticles that can penetrate deep into the lungs. The pollution forms within minut...

Scientists in Pontedera, Italy, created nanotubes just 500 nanometers wide that can heat up, release antioxidants, and electrically stimulate cells. These 3-in-1 nanoparticles may help treat cancer and brain diseases.

MIT engineers have found a way to stabilize the lipid nanoparticles used to deliver RNA vaccines, which could allow the vaccines to be more widely distributed.

The research group at the Istituto Italiano di Tecnologia in Pontedera (Pisa), led by Gianni Ciofani, has developed new organic nanoparticles that combine multiple therapeutic functions in a single material for the first time.

Silver–selenium nanoparticles (Ag–Se NPs) were successfully prepared using Punica granatum peel extract via a green, eco-friendly, and cost-effective approach. The formation of nanoparticles was…

Villiger, L. et al. CRISPR technologies for genome, epigenome and transcriptome editing. Nat. Rev. Mol. Cell Biol. 25, 464–487 (2024). Pacesa, M., Pelea, O. & Jinek, M. Past, present, and future of CRISPR genome editing technologies. Cell 187, 1076–1100 (2024). Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. & Liu, D. R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420–424 (2016). Gaudelli, N. M. et al. Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage. Nature 551, 464–471 (2017). Chemello, F., Olson, E. N. & Bassel-Duby, R. CRISPR-editing therapy for Duchenne muscular dystrophy. Hum. Gene. Ther. 34, 379–387 (2023). Xu, W., Zhang, S., Qin, H. & Yao, K. From bench to bedside: cutting-edge applications of base editing and prime editing in precision medicine. J. Transl. Med. 22, 1133 (2024). Leonard, A. & Tisdale, J. F. A new frontier: FDA approvals for gene therapy in sickle cell disease. Mol. Ther. 32, 264–267 (2024). Raguram, A., Banskota, S. & Liu, D. R. Therapeutic in vivo delivery of gene editing agents. Cell 185, 2806–2827 (2022). Bulcha, J. T., Wang, Y., Ma, H., Tai, P. W. L. &...

Akina, Inc. is a research company located in West Lafayette, Indiana near Purdue University. Founded in 2001 by Dr. Kinam Park, Akina provides a variety of research products and services with a focus on controlled release, medicinal-delivery, and biomedical applications. Akina consists of two divisions. PolySciTech is the products division and Akinalytics is the laboratory services division.

Atomic electron tomography resolves nucleation and growth in multi-principal-element alloy nanoparticles, revealing gradient structural ordering coupled to the local chemical order.

Abstract. The development of multifunctional biomaterials capable of simultaneously activating endogenous growth factors, promoting rapid hemostasis, and e

RNA vaccines and other nucleic acid therapeutics are typically packaged within fatty molecules known as lipid nanoparticles (LNPs). MIT researchers have now developed a way to produce these particles much more quickly and with more precise control over their size and shape.

MIT engineers have used a transformer-based AI algorithm to design heat-stable lipid nanoparticles that protect fragile mRNA molecules without requiring cold-chain refrigeration. In experiments publi…

RNA vaccines and other nucleic acid therapeutics are typically packaged within fatty molecules known as lipid nanoparticles (LNPs).